☰

Jennifer L. Lachey, Ph.D. - Publications

Affiliations: 
2002 University of Cincinnati, Cincinnati, OH 
Area:
obesity
Tree Info Grants Similar researchers PubMed Report error

22 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2014 Rao RR, Long JZ, White JP, Svensson KJ, Lou J, Lokurkar I, Jedrychowski MP, Ruas JL, Wrann CD, Lo JC, Camera DM, Lachey J, Gygi S, Seehra J, Hawley JA, et al. Meteorin-like is a hormone that regulates immune-adipose interactions to increase beige fat thermogenesis. Cell. 157: 1279-91. PMID 24906147 DOI: 10.1016/J.Cell.2014.03.065  0.76
2014 Li J, Geisbush TR, Rosen GD, Lachey J, Mulivor A, Rutkove SB. Electrical impedance myography for the in vivo and ex vivo assessment of muscular dystrophy (mdx) mouse muscle. Muscle & Nerve. 49: 829-35. PMID 24752469 DOI: 10.1002/Mus.24086  0.76
2014 Lawlor MW, Viola MG, Meng H, Edelstein RV, Liu F, Yan K, Luna EJ, Lerch-Gaggl A, Hoffmann RG, Pierson CR, Buj-Bello A, Lachey JL, Pearsall S, Yang L, Hillard CJ, et al. Differential muscle hypertrophy is associated with satellite cell numbers and Akt pathway activation following activin type IIB receptor inhibition in Mtm1 p.R69C mice. The American Journal of Pathology. 184: 1831-42. PMID 24726641 DOI: 10.1016/j.ajpath.2014.03.003  0.76
2012 Koncarevic A, Kajimura S, Cornwall-Brady M, Andreucci A, Pullen A, Sako D, Kumar R, Grinberg AV, Liharska K, Ucran JA, Howard E, Spiegelman BM, Seehra J, Lachey J. A novel therapeutic approach to treating obesity through modulation of TGFβ signaling. Endocrinology. 153: 3133-46. PMID 22549226 DOI: 10.1210/En.2012-1016  0.76
2011 Carlson CG, Bruemmer K, Sesti J, Stefanski C, Curtis H, Ucran J, Lachey J, Seehra JS. Soluble activin receptor type IIB increases forward pulling tension in the mdx mouse Muscle and Nerve. 43: 694-699. PMID 21462203 DOI: 10.1002/Mus.21944  0.76
2011 Pistilli EE, Bogdanovich S, Goncalves MD, Ahima RS, Lachey J, Seehra J, Khurana TS. Targeting the activin type IIB receptor to improve muscle mass and function in the mdx mouse model of Duchenne muscular dystrophy American Journal of Pathology. 178: 1287-1297. PMID 21356379 DOI: 10.1016/j.ajpath.2010.11.071  0.76
2011 Lawlor MW, Read BP, Edelstein R, Yang N, Pierson CR, Stein MJ, Wermer-Colan A, Buj-Bello A, Lachey JL, Seehra JS, Beggs AH. Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice. The American Journal of Pathology. 178: 784-93. PMID 21281811 DOI: 10.1016/j.ajpath.2010.10.035  0.76
2011 Donato J, Cravo RM, Frazão R, Gautron L, Scott MM, Lachey J, Castro IA, Margatho LO, Lee S, Lee C, Richardson JA, Friedman J, Chua S, Coppari R, Zigman JM, et al. Leptin's effect on puberty in mice is relayed by the ventral premammillary nucleus and does not require signaling in Kiss1 neurons. The Journal of Clinical Investigation. 121: 355-68. PMID 21183787 DOI: 10.1172/Jci45106  0.76
2011 Lawlor MW, Read BP, Edelstein R, Yang N, Pierson CR, Stein MJ, Wermer-Colan A, Buj-Bello A, Lachey JL, Seehra JS, Beggs AH. Inhibition of activin receptor type IIB increases strength and lifespan in myotubularin-deficient mice (The American Journal of Pathology (2011) 178 (784-793)) American Journal of Pathology. 178: 1406. DOI: 10.1016/j.ajpath.2011.01.007  0.76
2010 Goncalves MD, Pistilli EE, Balduzzi A, Birnbaum MJ, Lachey J, Khurana TS, Ahima RS. Akt deficiency attenuates muscle size and function but not the response to ActRIIB inhibition. Plos One. 5: e12707. PMID 20856813 DOI: 10.1371/Journal.Pone.0012707  0.76
2010 Koncarevic A, Cornwall-Brady M, Pullen A, Davies M, Sako D, Liu J, Kumar R, Tomkinson K, Baker T, Umiker B, Monnell T, Grinberg AV, Liharska K, Underwood KW, Ucran JA, ... ... Lachey J, et al. A soluble activin receptor type IIb prevents the effects of androgen deprivation on body composition and bone health. Endocrinology. 151: 4289-300. PMID 20573726 DOI: 10.1210/En.2010-0134  0.76
2010 Cadena SM, Tomkinson KN, Monnell TE, Spaits MS, Kumar R, Underwood KW, Pearsall RS, Lachey JL. Administration of a soluble activin type IIB receptor promotes skeletal muscle growth independent of fiber type. Journal of Applied Physiology (Bethesda, Md. : 1985). 109: 635-42. PMID 20466801 DOI: 10.1152/Japplphysiol.00866.2009  0.76
2010 Pistilli EE, Bogdanovich S, Mosqueira M, Lachey J, Seehra J, Khurana TS. Pretreatment with a soluble activin type IIB receptor/Fc fusion protein improves hypoxia-induced muscle dysfunction American Journal of Physiology - Regulatory Integrative and Comparative Physiology. 298: R96-R103. PMID 19864340 DOI: 10.1152/ajpregu.00138.2009  0.76
2009 Akpan I, Goncalves MD, Dhir R, Yin X, Pistilli EE, Bogdanovich S, Khurana TS, Ucran J, Lachey J, Ahima RS. The effects of a soluble activin type IIB receptor on obesity and insulin sensitivity International Journal of Obesity. 33: 1265-1273. PMID 19668253 DOI: 10.1038/ijo.2009.162  0.76
2009 Scott MM, Lachey JL, Sternson SM, Lee CE, Elias CF, Friedman JM, Elmquist JK. Leptin targets in the mouse brain. The Journal of Comparative Neurology. 514: 518-32. PMID 19350671 DOI: 10.1002/Cne.22025  0.76
2009 Morrison BM, Lachey JL, Warsing LC, Ting BL, Pullen AE, Underwood KW, Kumar R, Sako D, Grinberg A, Wong V, Colantuoni E, Seehra JS, Wagner KR. A soluble activin type IIB receptor improves function in a mouse model of amyotrophic lateral sclerosis. Experimental Neurology. 217: 258-68. PMID 19285073 DOI: 10.1016/j.expneurol.2009.02.017  0.76
2005 Zigman JM, Nakano Y, Coppari R, Balthasar N, Marcus JN, Lee CE, Jones JE, Deysher AE, Waxman AR, White RD, Williams TD, Lachey JL, Seeley RJ, Lowell BB, Elmquist JK. Mice lacking ghrelin receptors resist the development of diet-induced obesity. The Journal of Clinical Investigation. 115: 3564-72. PMID 16322794 DOI: 10.1172/Jci26002  0.76
2005 Zhou L, Williams T, Lachey JL, Kishi T, Cowley MA, Heisler LK. Serotonergic pathways converge upon central melanocortin systems to regulate energy balance. Peptides. 26: 1728-32. PMID 15993514 DOI: 10.1016/J.Peptides.2004.12.028  0.76
2005 Lachey JL, D'Alessio DA, Rinaman L, Elmquist JK, Drucker DJ, Seeley RJ. The role of central glucagon-like peptide-1 in mediating the effects of visceral illness: differential effects in rats and mice. Endocrinology. 146: 458-62. PMID 15459118 DOI: 10.1210/En.2004-0419  0.76
2002 Tamashiro KL, Wakayama T, Akutsu H, Yamazaki Y, Lachey JL, Wortman MD, Seeley RJ, D'Alessio DA, Woods SC, Yanagimachi R, Sakai RR. Cloned mice have an obese phenotype not transmitted to their offspring. Nature Medicine. 8: 262-7. PMID 11875497 DOI: 10.1038/Nm0302-262  0.76
2000 Lachey J, Profitt J, Foradori C, Seeley RJ. Combining non-isotopic localization of NPY mRNA with immunocytochemistry. Methods in Molecular Biology (Clifton, N.J.). 153: 199-206. PMID 10957994 DOI: 10.1385/1-59259-042-X:199  0.76
2000 Benoit SC, Schwartz MW, Lachey JL, Hagan MM, Rushing PA, Blake KA, Yagaloff KA, Kurylko G, Franco L, Danhoo W, Seeley RJ. A novel selective melanocortin-4 receptor agonist reduces food intake in rats and mice without producing aversive consequences. The Journal of Neuroscience : the Official Journal of the Society For Neuroscience. 20: 3442-8. PMID 10777807 DOI: 10.1523/Jneurosci.20-09-03442.2000  0.76
Show low-probability matches.